Decreased Bone Mineral Density during GnRH Analog Therapy and Polymorphism of Estrogen Receptor Gene in Precocious Puberty
article
OA: bronze
CC0
AI-generated summary
This study investigated the relationship between decreased bone mineral density during GnRH analog therapy and estrogen receptor gene polymorphism in children with precocious puberty.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
plays an important role in bone maturation and bone mineralization during puberty We previously reported that bone mineral accretion was not adversely affected by short time
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (7)
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
- W1990513576 via openalex
- W2015325027 via openalex
- W1978286040 via openalex
- W2024983547 via openalex
- W2061560374 via openalex
- W2063518962 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK